Read + Share
. Erratum: Anti-Granulocyte-Macrophage Colony-Stimulating Factor Monoclonal
Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind,
Placebo-controlled Trial. Am J Respir Crit Care Med 2022;206:801.
PMID: 36112778
|
 |
|
. Erratum: Anti-Granulocyte-Macrophage Colony-Stimulating Factor Monoclonal
Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind,
Placebo-controlled Trial. Am J Respir Crit Care Med 2022;206:801.
PMID: 36112778
|
|
|
|